Transcriptomics

Dataset Information

0

Expression data from lung SCC treated with DMSO and PXD101


ABSTRACT: We used microarrays to detail the global programme of gene expression in lung SCC cells treated with belinostat, a pan-HDAC inhibitor. The primary focus of this work is to investigate the efficacy of belinostat on lung SCC cells. Our phosphoproteomic profiling analyses revealed the downregulation of MAPK signaling pathway upon drug treatment, together with the induction of apoptosis. While HDAC inhibition generally affects transcription, the mechanism of SOS/MAPK downregulation was therefore proposed to be affected at the transcriptomic level. However, genes related to MAPK pathway were not significantly regulated upon belinostat treatment, whereas ubiquitin-proteasome gene signature was affected. This supports an indirect mechanism of epigenetic regulation on MAPK signaling that should be explored further.

ORGANISM(S): Homo sapiens

PROVIDER: GSE85979 | GEO | 2017/08/31

SECONDARY ACCESSION(S): PRJNA339921

REPOSITORIES: GEO

Similar Datasets

2015-01-27 | E-GEOD-65291 | biostudies-arrayexpress
2015-01-27 | GSE65291 | GEO
2019-03-01 | GSE111313 | GEO
2010-05-14 | E-GEOD-14859 | biostudies-arrayexpress
2019-01-08 | GSE123716 | GEO
2010-02-10 | GSE14859 | GEO
2017-09-08 | GSE74117 | GEO
2019-03-01 | GSE111314 | GEO
2019-03-01 | GSE111335 | GEO
2010-02-09 | E-GEOD-15079 | biostudies-arrayexpress